Articles Tagged With:
-
Clinical Briefs in Primary Care
How to Improve Office-based Colon Cancer Screening?; Extended-release Carvedilol + Lisinopril in Hypertension; Aspirin Resistance and Established Hypertension; Dementia and Aggressive Behavior; Dabigatran vs Warfarin for AFib; When Should a Non-diabetic A1c Be Rechecked? -
Pharmacology Watch
-
Bell's palsy: Corticosteroids and/or antivirals?
-
FDA Actions
-
Rasagiline and Parkinson's disease
-
CDC issues new vaccine recommendations
-
Use of SSRIs during pregnancy
-
Internal Medicine Alert - Full October 15, 2010 Issue in PDF
-
Pharmacology Watch
The World Health Organization (WHO) has issued a global alert and response regarding the use of antivirals for pandemic H1N1 flu, reiterating that antivirals should be used to prevent severe illness and death in children and adults. -
Clinical Briefs By Louis Kuritzky, MD
FDA-approved pharmacologic treatments for fibromyalgia (FIB) include duloxetine, milnacipran, and pregabalin. Although each of these agents has shown both statistically significant and clinically relevant impact, few patients are relieved of all problematic symptoms. Hence, additional treatment paths for FIB are sought.